{"date":"2026-05-12","count":70,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4116-2026-05-12-1954-qk9emb","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"19:54:18","subject":"代重要子公司凱圖國際股份有限公司公告董事會決議115年股東常會議程增列討論事項","clause":"第17款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-05-12 19:54，「代重要子公司凱圖國際股份有限公司公告董事會決議115年股東常會議程增列討論事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-05-12-1922-aixvg1","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-12","time":"19:22:35","subject":"公告本公司自主開發擁有全球開發權利的表觀遺傳免疫活化新藥GNTbm-38，已經獲得中國NMPA的IND審查核准，進入臨床一期試驗。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-05-12 19:22，「公告本公司自主開發擁有全球開發權利的表觀遺傳免疫活化新藥GNTbm-38，已經獲得中國NMPA的IND審查核准，進入臨床」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-05-12-1904-bz6tfr","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"19:04:55","subject":"公告本公司民國115年度第一季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-05-12 19:04，「公告本公司民國115年度第一季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-12-1852-svc53o","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:52:47","subject":"公告本公司將召開投資人可參與之重大訊息記者會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-12 18:52，「公告本公司將召開投資人可參與之重大訊息記者會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-12-1843-1dsh5xl","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:43:01","subject":"本公司因有重大訊息待公布，經櫃買中心同意自115年5月13日起暫停交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-12 18:43，「本公司因有重大訊息待公布，經櫃買中心同意自115年5月13日起暫停交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-05-12-1836-9h0ctm","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:36:03","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-05-12 18:36，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-05-12-1823-10xkf3m","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:23:59","subject":"更正公告本公司會計主管異動","clause":"第8款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-05-12 18:23，「更正公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-05-12-1821-jpizg6","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:21:56","subject":"公告本公司董事會決議發行員工認股權憑證","clause":"第11款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-05-12 18:21，「公告本公司董事會決議發行員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-05-12-1821-9bfmfe","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:21:34","subject":"本公司董事會決議第一季不分派股利","clause":"第14款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-05-12 18:21，「本公司董事會決議第一季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-05-12-1820-9h0ctm","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:20:40","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-05-12 18:20，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-05-12-1819-1egfkms","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:19:42","subject":"公告本公司董事會通過重要決議","clause":"第53款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-05-12 18:19，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-05-12-1811-5k8dg","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:11:29","subject":"公告本公司董事會通過115年第一季合併財務報表","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-05-12 18:11，「公告本公司董事會通過115年第一季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-05-12-1806-5lrh5b","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:06:22","subject":"公告本公司董事會通過解除經理人競業禁止之限制案","clause":"第21款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-05-12 18:06，「公告本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-05-12-1806-io8xzp","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"18:06:04","subject":"本公司財務及會計主管異動","clause":"第8款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-05-12 18:06，「本公司財務及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-12-1803-1fd3xmc","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-12","time":"18:03:56","subject":"公告本公司115年第一次現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-12 18:03，「公告本公司115年第一次現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-05-12-1803-9h0ctm","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"18:03:09","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-05-12 18:03，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-05-12-1802-p67uuk","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"18:02:35","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-05-12 18:02，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-05-12-1802-1mwjljt","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-12","time":"18:02:32","subject":"公告本公司董事會通過115年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-05-12 18:02，「公告本公司董事會通過115年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-05-12-1755-ayn3zi","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:55:53","subject":"補充公告本公司董事會決議召開115年股東常會相關事宜(因應電子投票自動轉入格式規定，故配合重新上傳)","clause":"第17款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-05-12 17:55，「補充公告本公司董事會決議召開115年股東常會相關事宜(因應電子投票自動轉入格式規定，故配合重新上傳)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-05-12-1735-15i7z9a","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:35:44","subject":"公告本公司董事會決議通過115年第1季財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-05-12 17:35，「公告本公司董事會決議通過115年第1季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-05-12-1734-q6gesb","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:34:31","subject":"(更正)本公司董事會決議買回本公司股份案","clause":"第35款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-05-12 17:34，「(更正)本公司董事會決議買回本公司股份案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-05-12-1732-1u5afzs","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:32:41","subject":"公告本公司董事會決議通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-05-12 17:32，「公告本公司董事會決議通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-05-12-1732-11i2rlg","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:32:03","subject":"代子公司致瑩生技(股)公司公告董事會決議114年度不發放股利","clause":"第14款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-05-12 17:32，「代子公司致瑩生技(股)公司公告董事會決議114年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-05-12-1731-vkseup","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:31:49","subject":"代子公司致瑩生技(股)公司公告董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-05-12 17:31，「代子公司致瑩生技(股)公司公告董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-05-12-1728-1p0jqzb","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:28:26","subject":"代子公司欣大首美達(股)公司公告董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-05-12 17:28，「代子公司欣大首美達(股)公司公告董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-05-12-1728-dezo76","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:28:07","subject":"公告本公司115年度第1季合併財務報告經董事會通過","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-05-12 17:28，「公告本公司115年度第1季合併財務報告經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-05-12-1728-19mrbuu","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:28:03","subject":"代子公司欣大首美達(股)公司公告董事會決議114年度不發放股利","clause":"第14款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-05-12 17:28，「代子公司欣大首美達(股)公司公告董事會決議114年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-05-12-1726-1tbiu7b","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:26:20","subject":"公告本公司董事會通過115年第1季合併財報務告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-05-12 17:26，「公告本公司董事會通過115年第1季合併財報務告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-05-12-1718-9h0ctm","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:18:21","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-05-12 17:18，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-12-1717-196wf6","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:17:12","subject":"公告本公司預計於新台幣5億元額度內取得有價證券","clause":"第20款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-12 17:17，「公告本公司預計於新台幣5億元額度內取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-05-12-1712-tjxx6d","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:12:50","subject":"本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-05-12 17:12，「本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-05-12-1712-l7qirp","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:12:42","subject":"公告本公司會計主管異動","clause":"第8款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-05-12 17:12，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-05-12-1712-1bs48eu","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:12:34","subject":"本公司民國115年第一季合併財務報告業經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-05-12 17:12，「本公司民國115年第一季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-05-12-1711-xo2pc7","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:11:04","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-05-12 17:11，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-05-12-1710-b9gsdb","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:10:41","subject":"公告本公司員工認股權憑證轉換普通股之增資基準日","clause":"第11款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-05-12 17:10，「公告本公司員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-05-12-1710-9h0ctm","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"17:10:10","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-05-12 17:10，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-05-12-1700-zaw2nq","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:00:55","subject":"代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形","clause":"第51款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-05-12 17:00，「代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-05-12-1700-wad9wo","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"17:00:06","subject":"公告董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-05-12 17:00，「公告董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-05-12-1659-pmh2je","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"16:59:21","subject":"公告本公司股東會決議通過解除董事之競業禁止","clause":"第21款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-05-12 16:59，「公告本公司股東會決議通過解除董事之競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-05-12-1659-15b5xff","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"16:59:06","subject":"補充公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-05-12 16:59，「補充公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-05-12-1657-3il1nf","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"16:57:57","subject":"公告本公司115年度股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-05-12 16:57，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-05-12-1646-ldksol","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:46:31","subject":"本公司董事會決議第2次買回庫藏股","clause":"第35款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-05-12 16:46，「本公司董事會決議第2次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-05-12-1645-eilcb5","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:45:46","subject":"董事會變更114年8月7日所通過的子公司間資金貸與還款期限","clause":"第53款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-05-12 16:45，「董事會變更114年8月7日所通過的子公司間資金貸與還款期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-05-12-1645-540svh","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:45:17","subject":"董事會通過修訂第1次買回庫藏股之買回股份轉讓員工辦法","clause":"第53款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-05-12 16:45，「董事會通過修訂第1次買回庫藏股之買回股份轉讓員工辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-05-12-1644-uj7vrs","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:44:46","subject":"本公司為子公司背書保證符合資金貸與及背書保證處理準則第25條第1項第4款情事","clause":"第22款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-05-12 16:44，「本公司為子公司背書保證符合資金貸與及背書保證處理準則第25條第1項第4款情事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-05-12-1643-3mn3s9","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:43:20","subject":"本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-05-12 16:43，「本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-05-12-1628-mh7cat","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:28:15","subject":"公告更正本公司114年度個別財務報告附註、iXBRL部份資訊及115年1月至3月關係人交易申報之部分資訊","clause":"第53款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-05-12 16:28，「公告更正本公司114年度個別財務報告附註、iXBRL部份資訊及115年1月至3月關係人交易申報之部分資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-05-12-1610-sqadl4","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:10:22","subject":"公告本公司國內第九次無擔保轉換公司債收足應募價款","clause":"第53款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-05-12 16:10，「公告本公司國內第九次無擔保轉換公司債收足應募價款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-12-1607-1b5u728","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:07:08","subject":"更正5月8日召開本公司115年股東常會(更正事實發生日)","clause":"第17款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-12 16:07，「更正5月8日召開本公司115年股東常會(更正事實發生日)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-05-12-1600-1los4z8","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"16:00:34","subject":"本公司資安主管異動","clause":"第8款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-05-12 16:00，「本公司資安主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-05-12-1559-9h0ctm","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"15:59:35","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-05-12 15:59，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-05-12-1543-1kvscgy","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"15:43:46","subject":"本公司取得生產設備，同一對象一年內累積金額逾新台幣五億元","clause":"第20款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-05-12 15:43，「本公司取得生產設備，同一對象一年內累積金額逾新台幣五億元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-05-12-1541-1n1n64","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"15:41:41","subject":"公告本公司提報董事會115年度第1季合併財務報表","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-05-12 15:41，「公告本公司提報董事會115年度第1季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-05-12-1534-i043eu","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"15:34:28","subject":"公告本公司董事會通過營業地址變更案","clause":"第53款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-05-12 15:34，「公告本公司董事會通過營業地址變更案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-05-12-1534-1ujeygm","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"15:34:19","subject":"公告本公司董事會決議召開115年股東常會相關事宜(增列其他事項)","clause":"第17款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-05-12 15:34，「公告本公司董事會決議召開115年股東常會相關事宜(增列其他事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-05-12-1533-16febev","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"15:33:37","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-05-12 15:33，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-05-12-1517-1u5afzs","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"15:17:55","subject":"公告本公司董事會決議通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-12","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-05-12 15:17，「公告本公司董事會決議通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-05-12-1516-hmgf2c","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"15:16:26","subject":"本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-05-12 15:16，「本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-05-12-1512-176g7i3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"15:12:00","subject":"本公司董事會決議買回本公司股份案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-05-12 15:12，「本公司董事會決議買回本公司股份案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-12-1442-pu9gcw","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"14:42:49","subject":"本公司董事會決議召開民國115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-12 14:42，「本公司董事會決議召開民國115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-12-1442-qhithg","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"14:42:19","subject":"本公司受邀參加花旗環球證券之2026Q1線上法說會議","clause":"第12款","fact_date":"2026-05-13","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-12 14:42，「本公司受邀參加花旗環球證券之2026Q1線上法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-12-1437-rv5ijk","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"14:37:08","subject":"本公司董事會決議通過114年度股東常會通過之私募普通股案不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-12 14:37，「本公司董事會決議通過114年度股東常會通過之私募普通股案不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-12-1436-1cnol71","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"14:36:10","subject":"依「公開發行公司資金貸與及背書保證處理準則」第22條第一項第三款規定公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-12 14:36，「依「公開發行公司資金貸與及背書保證處理準則」第22條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-12-1432-s4zf0d","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"14:32:54","subject":"公告本公司董事會決議辦理現金增資私募普通股定價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-12 14:32，「公告本公司董事會決議辦理現金增資私募普通股定價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-12-1431-1m5pp1c","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"14:31:52","subject":"公告本公司董事會決議配合轉投資公司圓祥生技股份有限公司上櫃過額配售作業","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-12 14:31，「公告本公司董事會決議配合轉投資公司圓祥生技股份有限公司上櫃過額配售作業」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-12-1431-1fzallu","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"14:31:45","subject":"公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第三款之公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-12 14:31，「公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第三款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-12-1431-t56g56","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"14:31:21","subject":"本公司民國115年度第一季合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-12 14:31，「本公司民國115年度第一季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-12-1430-9h0ctm","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"14:30:56","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-12 14:30，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-05-12-1336-9h0ctm","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-05-12","time":"13:36:34","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-05-12 13:36，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-05-12-1025-174u8f","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-05-12","time":"10:25:50","subject":"本公司回應媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-05-12 10:25，「本公司回應媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}